These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8215466)

  • 1. [Chemotherapy for soft tissue sarcoma--current concepts and review].
    Umeda T; Ishii T; Hatakeyama K; Wakita H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.
    Bramwell VH
    Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of soft tissue sarcoma in adults].
    Rouëssé J; Spielmann M; Le Chevalier T; Tubiana-Hulin M; Tursz T
    Bull Acad Natl Med; 1991 Nov; 175(8):1251-9; discussion 1259-60. PubMed ID: 1809496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for soft-tissue sarcomas.
    Elias AD
    Clin Orthop Relat Res; 1993 Apr; (289):94-105. PubMed ID: 8472436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ifosfamide in the treatment of sarcomas.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM; Patel S
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant chemotherapy of soft tissue sarcoma].
    Shinohara N; Yokoyama K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J; Kellner R; Seeber S
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic adjuvant chemotherapy for soft tissue sarcomas.
    Zalupski MM; Baker LH
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):787-800. PubMed ID: 7490241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
    Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in early soft tissue sarcoma and palliative chemotherapy in advanced soft tissue sarcoma in adults].
    Sauer H
    Praxis (Bern 1994); 1998 Aug; 87(34):1066-71. PubMed ID: 9757790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
    Budach V
    Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.